Pharma Market Access Insights - from Petauri Evidence
This podcast explores news and insights from global healthcare markets, offering advice on how pharma and medtech companies should respond and adapt their market access strategy. Each episode features insights from Petauri Evidence's associates across global healthcare, along with thought leadership from their market access and HEOR experts.
Episodes
Designing a Global Market Access Strategy Built for MFN
Send us Fan MailHow will Most Favored Nation (MFN) pricing reshape global pharmaceutical strategy? What do emerging Centers for Medicare & Medicaid Service (CMS) models such as GENEROUS, GLOBE, and GUARD mean for launch planning, pricing corridors, and payer expectations worldwide? How should global market access teams prepare for a more transparent and tightly connected pricing environment?MF
LATAM Market Access Unlocked: Insights from Argentina, Brazil, Colombia, and Mexico
Send us Fan MailHow do LATAM healthcare markets differ and what do these differences mean for Pharma and Medtech launch planning? What should global market access teams know to support affiliates in Argentina, Brazil, Colombia, and Mexico? How do evidence requirements, access routes, and payer expectations vary across the region?For global market access teams planning for launch in Latin America (
The Evolving NHS – An ICS Chief Pharmacist’s Perspective
Send us Fan MailWhat does the evolving NHS landscape look like through the eyes of a Chief Pharmacist, and how are integrated care system (ICS) pharmacy teams responding?In this Petauri Evidence NHS Whispers session, we put your questions to Yousaf Ahmad (Chief Pharmacist and Director of Medicines Optimisation, Frimley ICS), as he shares how he and his colleagues are responding to the changing NHS
First to Market: Unlocking Switzerland’s Pharma Potential
Send us Fan MailWhat makes Switzerland a compelling first-launch market for Pharma? How does its healthcare system compare to other European countries? What do manufacturers need to know about reimbursement, pricing, and evidence requirements? How might the evolving Joint Clinical Assessment (JCA) landscape influence launch sequencing?This episode explores Switzerland’s potential as an early launc
Q&A Webinar: The Evolving NHS Landscape in England – From Policy to Practice
Send us Fan MailIn this NHS Whispers live Q&A webinar, Katie Mulholland (Senior Consultant, UK Market Access, Petauri Evidence) speaks to: - Sarah Everest Ford (Programme Director, Health and Care Partnership) - Patrick McGee (Deputy Programme Director for Pathology, Lancashire & South Cumbria) - Prof. Phil Richardson (Former Dorset ICS System Commissioning Director; now Chief Innovation O
Global Pricing and Market Access – Strategies for Success in an Evolving Landscape
Send us Fan MailUncover the forces driving change in global pricing and accessIn this expert-led discussion we explore the latest trends, challenges, and strategic considerations shaping global pricing and market access (GPMA).At Petauri Evidence, our Global Pricing and Market Access Team are growing to meet the increasing complexity of global launch and access, bringing together fresh perspective
Transforming Global Market Access: Smarter Resource Management with Local Affiliates
Send us Fan MailDiscover a smarter way to manage and share market access resources with local affiliatesAre your global market access resources scattered, leading to inconsistencies and confusion among your affiliates? In this webinar we discussed how a centralised platform can streamline resource sharing, ensure access to nationally-relevant evidence, and put the resources your local affiliates n
Communicating value to US Payers: Insights for Pharma and Medtech
Send us Fan MailWhat do global market access teams need to know about the US market? What do US payers expect to hear from Pharma and Medtech companies? What kind of value messaging resonates in the US? How do you prepare for launch in a market as diverse as the US?In this Global Whispers episode, Louise Maddison (Senior Consultant – Global Market Access, Petauri Evidence) interviews some of our c
Navigating market access: Launch strategies and health economic modelling for medical devices
Send us Fan MailDiscover how health economics can support successful Medical Device launch, proposition development, and market accessThis episode offers an insightful journey into the world of medical device market access. Specialists from our health economics and market access teams explore the hidden challenges faced by medical devices companies when taking new innovations to healthcare leaders
Navigating US payer evidence needs to optimise market access
Send us Fan MailWhat clinical and economic evidence do US payers prefer to drive formulary decisions? How can you optimise your chances of preferential access in the US with the right evidence? How should evidence be generated, synthesised, and presented for the US market?In this episode, Clare Foy (Director – Global Market Access, Mtech Access) interviews colleagues Nicole Lodowski (Managing Dire
Best practice RWE approaches to support economic modelling for HTA
Send us Fan MailHow can real-world evidence (RWE) support health technology assessment (HTA)? Can real-world data (RWD) supplement clinical data? How can RWE be used to solve common challenges with treatment comparison?Here, Mtech Access are joined by experts from Arcturis and Delta Hat. Dan Howard (Associate Director – Health Economics, Mtech Access) shares some of the challenges that our clients
NHS winter planning 2024–25 – Engaging with NHS decision-makers through Autumn to Christmas
Send us Fan MailHow is the NHS preparing for winter? Which challenges are the most pressing for NHS decision-makers? How can industry best engage and support NHS decision-makers in the next few months?In August, Karen Cooper (Senior Consultant – NHS Insight & Interaction, Mtech Access) was joined by Jo Turl (Former Director of Commissioning, Devon ICS) to explore these challenges.Jo and Karen
De-mystifying the NHS – What you need to know about the NHS as a market for your health technology
Send us Fan MailAre you a global market access lead looking to understand the challenges faced by your UK affiliates? Or do you work at a national level with responsibility for bringing a new health technology to the NHS in England? In July 2024, Global Whispers and NHS Whispers came together, to bring you an overarching view of what it takes to access the NHS with a medtech or pharmaceutical inno
NHS primary care panel – the GP Contract and Operational Planning Guidance
Send us Fan MailWhat can we expect to see in primary care in the NHS given recent policy announcements and ongoing uncertainty? What does the new GP Contract tell us about the future of primary care? What are the biggest challenges facing primary care in 2024–25?In this webinar, Karen Cooper (Senior Consultant – NHS Insight & Interaction, Mtech Access) spoke to a panel of NHS Associates about
Engage NHS healthcare decision-makers with RWD
Send us Fan MailDiscover how data visualisation dashboards can aid field teams in market access discussions with customers. Healthcare leaders look to real-world data (RWD) to inform decisions. Field teams presenting decision-makers with RWD within a well-designed, easy-to-use visualisation can build a case for change, while positioning themselves as a trusted partner. Watch this 20-minute discuss
Market access and reimbursement in Canada – changes at CADTH
Send us Fan MailWhat do you need to know about the market access and reimbursement landscape in Canada? What changes can we expect at the Canadian Agency for Drugs and Technologies in Health (CADTH) in 2024/2025? In this webinar, Clare Foy (Director – Global Market Access, Mtech Access) interviewed Don Husereau (Adjunct Professor of Medicine, The University of Ottawa).We take a look at the market
Rare Disease market access in the MENA and Nordic regions
Send us Fan MailWhere will you be launching your new orphan medicine? You may be confident that your Global market access strategy will support access in key launch markets like the UK, the EU4 and the US, but have you thought about other markets? Have you looked at the reimbursement requirements for rare disease products in the Nordic markets? Have you explored opportunities in growth markets, su
How does funding flow in NHSE Regions?
Send us Fan MailWhich decisions are made at Region level in the NHS in England? How do finances and funding work at this level? And how can industry best support and engage with Region leaders?We sit down with guest speaker Richard Smale (Interim Director of System Co-ordination, NHS England [NHSE] – South West) for an all-encompassing discussion that explored finance, funding flows, system priori
NHS policy for 2024/25: strategy and engagement in a world of uncertainty (recorded in Jan 2024)
Send us Fan MailWhat do we know about plans and policy for 2024/25? As the expected central operating plan had not materialised (at time of recording), and with a general election and a potential Labour government on the horizon, how can NHS and industry drive forward improvements and innovation?Host Robert Hull (Senior Consultant – NHS Insight & Interaction, Mtech Access) was joined by guest
De-mystifying health economic model classifications and structures
Send us Fan MailWhat is health economic evaluation and which modelling approaches can be used to support market access activities?In this episode, our expert health economists explain the key strengths and limitations of the most common health economic modelling classifications and structures. Here, Hannah Gillies (Consultant – Health Economics) and Daniel MacDonald (Associate Consultant – Health
Evidence strategy for Medical Technologies and Diagnostics
Send us Fan MailHere, our experts explore evidence strategies for medical devices, diagnostics and digital health technologies.Have you established the clinical and economic value of your medical device, diagnostic or digital technology? Do you have the evidence required to support your value proposition? Would a health technology assessment (HTA) route be appropriate for your product? What will p
How to set your Pharma or Medtech product up for success in the US market
Send us Fan MailHow can you ensure your product is set up for success from early clinical trials right through to launch and commercialisation? In this Global Whispers webinar we explore best practice commercialisation strategy for healthcare products launching in the US market.Clare Foy (Director – Global Market Access, Mtech Access) speaks to Janice MacLennan (Pharma and Medtech brand strategist
What's happening with specialised commissioning in the NHS?
Send us Fan MailWhat’s happening with specialised commissioning in the NHS? How likely is a delay in delegation to integrated care boards (ICBs)? How and what should Pharma and Medtech plan for amidst all this uncertainty?Malcolm Qualie (former Medicines Lead for Specialised Services, NHS England) speaks to David Thorne (Principal Associate, Mtech Access) to explore specialised commissioning in th
Integrated care in NHS Wales – what can England learn from its neighbour?
Send us Fan MailWhat does it take to run a truly patient-centric integrated health system? What does the Welsh journey with integration tell us about the future for England?Paul Mears (CEO, Cwm Taf Morgannwg University Health Board) joins Robert Hull (Senior Consultant – NHS Insight & Interaction, Mtech Access) to explore the integrated care model in Wales and the lessons England can take from
Market access in Italy: Reforms at AIFA
Send us Fan MailClare Foy (Director – Global Market Access, Mtech Access) speaks to Italian market access expert Prof. Fabrizio Gianfrate (Professor of Health Economics and Outcomes Research [HEOR] and Ex-Payer) about the market access landscape in Italy, particularly regarding changes at the Agenzia Italiana del Farmaco (AIFA).We explore:- The nature of the Italian market and the reimbursement pr
Unmet need in NHS primary care – How can industry best support PCN leaders?
Send us Fan MailDr Farzana Hussain (GP Principal, The Project Surgery) and Prof. Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) explore the unmet needs of Primary Care Networks (PCNs) and how industry can best support primary care leaders and GPs as we head into winter, 2024 and beyond.Former ‘GP of the year’ and strategic influencer over primary care policy, Dr Farzana Hussain
Population health management: a community effort across health and life sciences
Send us Fan MailHow can our community support NHS leaders to deliver a data-led, people-centric health service?Dr Mark Davies (Global Chief Health Officer, IBM) joins Prof. Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) to explore the power of data, the role of community and how the health and life sciences ecosystem can support the NHS’s population health management goals.Popu
Artificial intelligence (AI) in clinical trials: Implications for evidence synthesis and market access
Send us Fan MailHow is Artificial Intelligence being used in the development of new medicines? What role can AI currently play in clinical trials? Where can AI bridge gaps and solve challenges? What could this mean for the future of market access?In this webinar, Dr George Magrath explains how his team at Lexitas are using AI in clinical trials in the field of ophthalmology. George and Calum explo
6 areas of UK health policy for Medtech to pay attention to
Send us Fan MailHow is the UK political landscape evolving and what does this mean for Health Technology and Medical Device innovators?Robert Hull (Senior Consultant – NHS Insight & Interaction, Mtech Access) speaks to William Lee (Head of Policy and Compliance, British Healthcare Trades Association [BHTA]) about health policy, regulation and its implications for Medtech, Health technologies,
Market access in the German speaking markets
Send us Fan MailHere we explore market access challenges in Germany, Austria and Switzerland. Clare Foy (Global Market Access Director – Mtech Access) speaks to Dr Stefan Walzer (CEO, President & Founder at MArS Market Access & Pricing Strategy GmbH) about the challenges and opportunities for reimbursement in the German-speaking markets.Clare and Stefan discuss: - Preparing for access to S
The role of nursing in driving digital change in the NHS
Send us Fan MailHow are nursing professionals supporting the digital evolution in UK healthcare? How can new technologies be leveraged by front-line clinical teams to support improved patient care? And how can Medtech, Digital and Biotech innovators collaborate with the front-line nursing teams in the NHS to drive transformation?Prof. Phil Richardson (Chair and Chief Innovation Officer, Mtech Acce
Market access for digital therapies and digital medicines
Send us Fan MailIn this Global Whispers webinar we explore market access for digital therapeutics. Clare Foy (Global Market Access Director – Mtech Access) speaks to Shefali Shah (Global VP, Market Value and Commercial Effectiveness – MindMaze) about the challenges and opportunities for digital therapies to gain market access and ultimately improve patient outcomes.In the webinar, Clare asks Shefa
A global market access journey in cannabinoid pharmaceuticals
Send us Fan MailWhat does it take to bring a cannabinoid pharmaceutical to market?We were delighted to welcome Michael Sassano (CEO – SOMAÍ Pharmaceuticals) as the first guest on our new Global Whispers webinar series. Michael shared with us his company’s experiences bringing new products to market, the challenges SOMAÍ Pharmaceuticals have faced and the lessons the Pharma industry can learn from
Primary Care and ICBs – what is the next step in the integration journey?
Send us Fan MailHow will changes to the structure of primary care impact decision making?How is the relationship between Integrated Care Boards (ICBs) and primary care stakeholders evolving? How will funding flows be impacted?Prof. Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) is joined by Tim Goodson (Executive Officer, Dorset General Practice Alliance) to explore how primary
Data-led transformation in the NHS - partnering to optimise patient care
Send us Fan MailIs data the key to transforming healthcare systems and patient care?What are the top priorities for digital transformation leaders in the NHS? How can Pharma and Medtech companies partner with the NHS to share data, transform services, and find smarter, faster way to improve patient care?Prof. Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) is joined by Stephen S
Innovating for better health – research, collaboration and innovation in the NHS
Send us Fan MailHow and where can innovation drive improvements in care and deliver better health for the population?How is the NHS looking to collaborate with key partners across industry and academia? What innovations are set to transform care? What role do Academic Health Science Networks (AHSNs) play and how can partners best engage with them?Prof Phil Richardson (Chair and Chief Innovation Of
Healthcare, economics and society – unlocking NHS collaboration
Send us Fan MailWill NHS leaders, as part of an Integrated Care System (ICS), make conscious decisions to drive economic and social change?What social and economic value do ICSs offer the wider population they serve? How will industry support ICSs to deliver population-based health and social benefits?Prof Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) is joined by Michael Wood
Specialised Commissioning in the NHS – What do you need to know now
Send us Fan MailThe proposed new NHSE systems for specialised commissioning are arguably the highest risk of all current dynamics, both for the NHS and for suppliers. Key aspects or policy have been published in ways that are hard to access and even harder to interpret. Here, we gather an expert panel to discuss what proposed new NHSE systems for specialised commissioning mean in practice.In this
Why are we waiting? - Pressures facing the NHS and how to deliver change
Send us Fan MailWith so many patients left waiting for NHS care, what will the long-term impact be? How can Pharma and Medtech support the NHS with systematic challenges, like waiting? Where can industry work with the NHS to improve patient flow to get people appropriate treatment sooner and limit the harm caused by waiting? Prof Phil Richardson (new Chief Innovation Officer, Mtech Access and unt
Priority setting in primary care - NHS insights
Send us Fan MailHow is the NHS balancing competing challenges as we head through integration and towards winter? How are priorities set and what does system planning look like in primary care?Dr Alex Degan (Primary Care Medical Director, Devon Integrated Care System [ICS]) joins Tom Clarke (Director, Mtech Access) to explore all this and more.In this episode, we explore how primary care leaders ar
Integrated Care Systems go live in the NHS - reflections after 3 weeks
Send us Fan MailOn 1st July we saw the introduction of legislation for Integrated Care Systems (ICSs) in the NHS. In the weeks since, what has changed for healthcare leaders, practitioners and patients? What are the key priorities for NHS decision-makers and what is getting in the way of change? How can Pharma and Medtech support their NHS customers as they implement this change?In this episode T
Clinical Pharmacists – exploring the scope, capabilities, and potential of this evolving NHS role
Send us Fan MailWhat roles and responsibilities do Clinical Pharmacists have in the NHS? How can Pharma and Medtech engage Clinical Pharmacists, and how can industry best support these new decision-makers?Tom Clarke (Director, Mtech Access) explores all this and more with Tom Kallis (Senior Clinical Pharmacist, East Cornwall PCN).They explore the origins of the Clinical Pharmacist role and how it
Transforming systems and care pathways for an integrated NHS
Send us Fan MailAs the NHS takes steps towards a more integrated future, how are systems and care pathways transforming? How is change being implemented, and what does this look like in reality for local systems and populations?Tom Clarke (Director, Mtech Access) explores all this and more with Debbie Morgan, (Director of Service Improvement and Transformation, Cambridge University Hospitals NHS F
Digital value payer communication tools: How to meet the needs of your internal stakeholders and customers
Send us Fan MailOur experts in health economics, value communication, design and digital discuss how to craft digital payer value communication tools to meet the needs of internal stakeholders, including market access teams and KAMs, and healthcare customers. What does a best-in-class value communication tool look like in 2022? What are the key considerations when developing a new payer value tool
Population to Person: How will the NHS translate population health management into impactful, person-centred service change?
Send us Fan MailWhat does population health management mean for the NHS, for patients, and for industry? How will the NHS translate population health management into impactful service change and what will this look like for patients?Tom Clarke (Director, Mtech Access) explores all this and more with guest speaker Dr Steven Laitner (GP, Parkbury House Surgery). Steven and Tom explore how the NHS ca
Planning in a volatile environment: how will the NHS reconcile its competing priorities and operational planning to meet its challenges?
Send us Fan MailWhat does the ‘2022/23 priorities and operational planning guidance’ document mean for the NHS, for Integrated Care System (ICS) development and for an NHS workforce still battling COVID? How realistic and achievable are the priorities set out, and how can Pharma and Medtech best help NHS leaders to achieve these goals?Caroline Dawe (Deputy Director of Commissioning, Bristol, North
The evolving NHS: How can Pharma and Medtech support the NHS in 2022? - NHS Insights Panel Discussion
Send us Fan MailPharma and Medtech professionals put questions to our panel of NHS associates as we reflected on the operational, structural, and clinical challenges the NHS has faced in 2021 and how Pharma and Medtech can best support the NHS in 2022.We were joined by some of Mtech Access’s closest and most insightful friends:- David Thorne (Director, Mtech Access and Well Up North PCN) our Polic
Optimising the NHS – How will medicines be valued in integrated systems?
Send us Fan MailHow will medicines be valued in the newly integrated world of the NHS? What are the risks and benefits of a single national formulary? What else is changing? And what does this mean for market access?Ellen Rule (Programme Director of the Gloucestershire Integrated Care System [ICS] and Director of Transformation and Service Redesign, Gloucestershire Clinical Commissioning Group [CC
Rare disease market access - strategic and tactical challenges facing orphan medicines entering Europe
Send us Fan MailWe explore the challenges facing orphan medicines and other innovative rare disease treatments looking to achieve market access in Europe.Orphan medicines and rare disease treatments are faced with a complex, ever-changing market landscape. These treatments also face unique tactical challenges on the route to securing market access.Here we bring together specialists from our global
A new paradigm for the NHS: Partnering to deliver lasting and meaningful care improvements - with Dr Phil Webb (Chief Executive of Respiratory Innovation Wales)
Send us Fan MailHow are healthcare systems looking differently at their population to deliver better care and what does this mean for future decision-making? How might the NHS re-imagine the hospital? What benefits can we expect from novel technologies, and can the NHS develop system resilience to improve healthcare outcomes?Dr Phil Webb (Chief Executive of Respiratory Innovation Wales) joined Tom
Innovations to address health inequalities in the NHS and how Pharma and Medtech can help
Send us Fan MailHow can the NHS address health inequalities through innovation? How can new health technologies help improve population health? How can Pharma, Medtech and the wider life sciences industry support the NHS with these goals? And what does the NHS’ ambitions in this area mean for your market access strategy?Jon Siddall (Chief Executive of the South West Academic Health Science Network
The hidden heroes of the NHS - The role of ambulance Trusts in keeping patients and systems moving
Send us Fan MailWhat role do Ambulance Trusts play in the success of the wider NHS? How might urgent and community care evolve as we head to integration as part of a joined-up system? How will an integrated ambulance service support system redesign to keep people out of hospital, and provide more proactive care to those who need it most?Helen Ray (Chief Executive of North East Ambulance Service NH
Population to person - How will the voice of the individual drive health and care development?
Send us Fan MailPopulation health management is often talked about in top-down terms, but how seriously will the needs of individuals be taken as systems develop? How will personal needs inform care delivery? Why will the patient voice play a very different role in the NHS of the future?Steph Edusei (Chief Executive of St Oswald’s Hospice) joins Tom Clarke (Director, Mtech Access) to explore these
Know your Place - where will power really sit in the new NHS - with Dr Steven Michael OBE
Send us Fan MailWhat will a ‘Place’ look like? What will this new layer of the NHS mean in practice and what decision-making powers will Place leaders have?As the NHS starts its journey towards an integrated future, Dr Steven Michael OBE (Chair of East Cheshire Partnership) joins Tom Clarke (Director, Mtech Access) to talk ‘Place’, ‘Partnership’, ’Collaboratives’ and more.The UK Government’s Heal
Health Economic Modelling for MedTech Innovation - What, Why and How
Send us Fan MailAre you looking to launch a new medical technology, medical or diagnostic device in the UK, Europe or North America? Would you like to know how health economic modelling could support your market access journey?In this episode, converted from a recent live webinar, Calum Jones (Consultant Health Economist) and Nick Swart (Senior Health Economist) discuss what, why and how health ec
Pharmacy, Medicines, and Specialised Commissioning in the new NHS
Send us Fan MailWhat changes can we expect to pharmacy, medicines management, and specialised commissioning in the new NHS? Professor Inderjit Singh (Chief Pharmacist at University Hospitals Birmingham) joins Tom Clarke (Director, Mtech Access) to explore all this and more. Professor Singh is one of the leading pharmacists in today’s NHS and is currently Chief Pharmacist at University Hospitals B
The White Paper and integrated care in the NHS: What it really means in practice for clinicians, patients and us - with Dr John Ribchester
Send us Fan MailAre you wondering what integrated care will look like when the Health and Care White Paper proposals become a reality? Tom Clarke interviews Dr John Ribchester about what the proposals means in practice for clinicians, for patients and for the life sciences industry. Dr Ribchester is a GP and Clinical Director of Whitstable Primary Care Network (PCN) in Kent and has led development
Heads at the heart of the NHS: How mental health is central to everything in the new NHS - with Brent Kilmurray (Chief Executive of Tees, Esk and Wear Valleys NHS Foundation Trust)
Send us Fan MailWith mental health services facing unique challenges, Brent Kilmurray (Chief Executive of Tees, Esk and Wear Valleys NHS Foundation Trust), joins Tom Clarke (Director, Mtech Access) to explore the challenges of leading mental health services in the NHS.As Chief Executive of the Tees, Esk and Wear Valleys NHS Foundation Trust, and with almost 20 years of experience in strategic and
Pharmacy and Medicines in the Integrated Care Systems (ICS) of the new NHS with Laura Angus
Send us Fan MailWith new policy passing power to Integrated Care Systems (ICS), we explore how pharmacy and medicines commissioning will work in the new system, with Laura Angus (Interim Lead Pharmacist, Humber, Coast and Vale ICS)In our December #WhispersWordsofWisdom webinar, Tom Clarke was joined by Laura Angus who, in her new appointment as a Lead Pharmacist in an Integrated Care System (ICS),
Is prevention better than the cure? How can the NHS and public health work closer to improve population health?
Send us Fan MailDr Peter Brambleby (Independent Public Health Consultant) joins Tom Clarke (Director, Mtech Access) to discuss the role public health has played through the COVID pandemic and its importance to the population going forward.This webinar forms part of our monthly Whispers’ Words of Wisdom series, in which we have in‑depth, comprehensive conversations with senior colleagues from the N
Understanding the tipping point: When elective becomes selective in NHS surgery
Send us Fan MailSimon Parsons (Divisional Director of Surgery at Nottingham University Hospitals NHS Trust) joins Tom Clarke (Director, Mtech Access) to discuss how decisions, such as the postponement of non-urgent elective surgery, are made, the impact this has on patients and staff, and how the NHS might adapt to provide care for these patients.In addition to his role as Divisional Director of S
Leading within an evolving, integrating system: insights from an NHS leader
Send us Fan MailDiscover what it’s like to be a leader in today’s NHS and how industry can best support NHS leaders. Deborah Lee (Chief Executive of Gloucestershire Hospitals NHS Trust) speaks to David Thorne (Director, Mtech Access) about how she and her colleagues are responding to the challenges presented by the COVID-19 pandemic, the resultant backlog in care, and the latest policy changes. De
Integrated Care Systems: Separating fact from myth – insights from a system leader
Send us Fan MailDr Claire Fuller (Senior Responsible Officer at Surrey Heartlands Health and Care Partnership) joins Tom Clarke(Director, Mtech Access) to discuss the evolving world of Integrated Care Systems (ICS). As Senior Responsible Officer for Surrey Heartlands Health and Care Partnership, Dr Fuller leads the delivery of plans to transform care for a population of over 850,000 people. Her ro
The Evolving NHS - Lessons for Pharma and Medtech - NHS insights webinar with David Thorne and Tom Clarke
Send us Fan MailFrom capacity management to changing performance measures, discover what’s changing in the NHS, the impact on the NHS long-term plan and what all this means for the future of market access. Tom Clarke and David Thorne, from the Mtech Access NHS Insights & Interaction team, review some of the insights from our earlier series: ‘How is COVID-19 impacting the NHS?’, as well as expl
The Role of the Independent Sector, Post-COVID with Jim Easton (CEO of Care UK)
Send us Fan MailWe are joined by Jim Easton (CEO of Care UK) to discuss the role of the independent sector in supporting the NHS and the wider care industry, both during the pandemic and in a post-COVID world. In this COVID-19 series, Tom Clarke (Director - NHS Insights & Interaction, Mtech Access) is joined by NHS and other UK healthcare experts who offer real-world, first-hand insight into
The Tech Perspective with Stephen Bourke (Co-Founder of Echo, The Online Pharmacy)
Send us Fan MailWe explore a different aspect of the COVID response, speaking with Stephen Bourke (Co-Founder of Echo), to learn how Echo and other tech companies have been supporting patients with new ways of accessing healthcare, throughout lockdown.In this COVID-19 series, Tom Clarke (Director - NHS Insights & Interaction, Mtech Access) is joined by NHS and other UK healthcare experts who
Questions Time Special - Views from across the NHS; from costings to strategy to clinical care
Send us Fan MailIn this 'Questions Time' special we welcome a broad panel of practitioners from across the NHS to explore the themes of care delivery, collaboration, innovation and governance. Our panellists are:Cameron Ward (Interim Director of Strategy and Outcomes, Sefton CCG)Hilary Snowdon (Management Lead, West Northumberland PCN)Patrick McGinley (Head of Costing & SLR, Maidston
The Changing Face of Care Delivery Part 2: The Primary Care & Community View with Steve Reed (Head of Community Services, York Teaching Hospitals NHS FT) and Dr John Ribchester (PCN Clinical Director, GP and Chair of Encompass GP Partnership, Whitstable)
Send us Fan MailWith Steve Reed (Head of Community Services, York Teaching Hospitals NHS FT) and Dr John Ribchester (PCN Clinical Director, GP and Chair of Encompass GP Partnership, Whitstable, Kent) as our guides, we revisit the changing face of care delivery, this time from the viewpoint of primary care and the community. Steve and John give us their perspectives on out of hospital care and how
The Changing Face of Care Delivery Part 1: The System & Hospital View with Berenice Groves (Director of Operations, Blackpool Teaching Hospitals NHS FT) and Tina Teague (COVID Resilience Manager for Devon)
Send us Fan MailIn this, the first of two sessions looking at the changing face of care delivery, Berenice Groves (Director of Operations, Blackpool Teaching Hospitals NHS FT) and Tina Teague (COVID Resilience Manager for Devon) explore the system and hospital view.In this COVID-19 series, Tom Clarke (Director - NHS Insights & Interaction, Mtech Access) asks experts holding operational, strat
Strategic Procurement & Medicines Management with Keith Pearson (Head of Medicines Optimisation, in a CCG) and Simon Wootton (Non Exec Director, in a PCN)
Send us Fan MailListen as Keith Pearson (Head of Medicines Optimisation, Heywood, Middleton and Rochdale CCG) and Simon Wootton (Non Exec Director, Rossendale West PCN) explore strategic procurement and medicines management, both in terms of the current pandemic and what the future may hold. In this COVID-19 series, Tom Clarke (Director - NHS Insights & Interaction, Mtech Access) asks experts
Pharmacy & Medicines Management with Samantha O’Connell (GP Clinical Pharmacist) and Johnathan Laird (Prescribing Pharmacist)
Send us Fan MailDiscover the opportunities and challenges facing pharmacy and medicines management in the NHS. We speak to Samantha O’Connell (GP Clinical Pharmacist) and Johnathan Laird (Prescribing Pharmacist and Founder of Pharmacy in Practice) about their experiences as pharmacists during the pandemic and their hopes for the future. In this COVID-19 series, Tom Clarke (Director - NHS Insights
Finance & Commissioning with Patrick McGinley (Head of Costings and SLR) and Patricia Whelan-Moss (Head of Organisational Development for a CCG)
Send us Fan MailWe explore the worlds of finance and commissioning in the NHS with insights from Patrick McGinley (Head of Costings and SLR, Maidstone & Tunbridge Wells NHS Trust) and Patricia Whelan-Moss (Head of Organisational Development – Brent CCG). In this COVID-19 series, Tom Clarke (Director - NHS Insights & Interaction, Mtech Access) asks experts holding operational, strategic an
Primary Care & Community Settings with Liz Cross (Advanced Nurse Practitioner) & Dr Su McCole (GP & Area Clinical Director)
Send us Fan MailWe focus in on primary care and community settings with insights from Liz Cross (Advanced Nurse Practitioner) and Dr Su McCole (GP & Area Clinical Director)In this COVID-19 series, Tom Clarke (Director - NHS Insights & Interaction, Mtech Access) asks experts holding operational, strategic and clinical roles across the NHS to share their experiences and insights into how th
Introductory overview with PCN lead Hilary Snowdon & Secondary Care Chief Exec Mike Proctor
Send us Fan MailIn our COVID-19 series, Tom Clarke (Director - NHS Insights & Interaction, Mtech Access) asks experts holding operational, strategic and clinical roles across the NHS to share their experiences and insights into how the NHS has responded to COVID-19 and the wider challenges facing the health service. This podcast has been converted from our webinar series 'How is COVID-19
Recommended
Jubal Phone Pranks from The Jubal Show
پلی لیست | PlayList
English with Olivia | Slow Conversations & Vocabulary
Bible Tea
TED Talks Daily
Pod Save America
Dateline NBC
صداستان: ساعتی با موسیقی
Becoming: HER with Nikki Spoelstra
Exposing Workplace Bullying
Everyday AI Made Simple - AI For Everyday Tasks
FemTech Focus
